LZO: Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented

Product code LZO, “Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented” in FDA's classification database, is a Class II device type under 21 CFR 888.3353 (hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis), reviewed by FDA's Orthopedic panel. FDA's 510(k) database lists 535 clearances under LZO, 235 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
LZO
Regulation
21 CFR 888.3353
Class
II
Panel
Orthopedic
Clearances
535
Most recent
Oct 1, 2026
Median review, last 2 years
102 days
Third-party review
Not eligible
Implant
Yes

What it covers

A hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis is a device intended to be implanted to replace a hip joint. This device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. The two-part femoral component consists of a femoral stem made of alloys to be fixed in the intramedullary canal of the femur by impaction with or without use of bone cement. The proximal end of the femoral stem is tapered with a surface that ensures positive locking with the spherical ceramic (aluminium oxide, A1203) head of the femoral component. The acetabular component is made of ultra-high molecular weight polyethylene or ultra-high molecular weight polyethylene reinforced with nonporous metal alloys, and used with or without bone cement.

The identification in 21 CFR 888.3353, hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis. FDA gives LZO no definition of its own, so the regulation’s describes it.

FDA flags LZO devices as implants.

Recent clearances

510(k)DeviceApplicantDecisionType
K262473NEXUS® Hip StemMicroport Orthopedics, Inc.Oct 1, 2026Special
K260173M-Vizion Femoral Revision System ExtensionMedacta International S.A.Sep 17, 2026Traditional
K253948Momentum Acetabular Cup SystemUnited Orthopedic CorporationSep 2, 2026Traditional
K261009MobileLink Acetabular Cup System – 40mm ID Inserts (various)Waldemar Link GmbH & Co. KGJul 6, 2026Traditional
K260831Z1 Hip SystemZimmer, Inc.Jun 16, 2026Traditional
K260182Avenir® Müller Stem; Avenir Complete™ Hip SystemZimmer, Inc.Apr 27, 2026Traditional
K260037implantcast Packaging System UpdateImplantcast GmbHMar 30, 2026Traditional
K252401implaFit® short stemsImplantcast GmbHMar 12, 2026Traditional
K253171Libertas Taper Short (TS) Uncemented Femoral Stem (Libertas TS Stem)Maxx Orthopedics, Inc.Jan 15, 2026Traditional
K250450Coated hip implantsMedacta International S.A.Sep 19, 2025Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 535 with a free account)

Clearances by year

235 LZO 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)9102
202514119
202411111
202310122
202211279
202112170
202018112
201928109
201818163
201716257
201610177
201512115
20141385
201326100
20121498
20111387

Who submits

56 applicants cleared a LZO device since 2011. 57% of the clearances went to applicants in United States, then Switzerland (14%), Germany (10%) and Taiwan (5%). By type: Traditional 75%, Special 24% and Abbreviated 1%.

ApplicantClearances since 2011
Medacta International S.A.24
Corin USA17
Microport Orthopedics, Inc.13
Smith & Nephew, Inc.12
Waldemar Link GmbH & Co. KG11
Implantcast GmbH10
Medacta International10
Zimmer GmbH10

How FDA classifies it

Class II.

From 21 CFR 888.3353.

Standards

21 CFR 888.3353 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent LZO clearances declared.

Ask about LZO

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about LZO

What is FDA product code LZO?

Product code LZO, “Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented” in FDA's classification database, is a Class II device type under 21 CFR 888.3353 (hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis), reviewed by FDA's Orthopedic panel. FDA's 510(k) database lists 535 clearances under LZO, 235 of them since 2011.

How many 510(k) clearances are there under LZO?

FDA’s 510(k) database listed 535 clearances under LZO as of Oct 29, 2026, 235 of them decided since 2011; the most recent decision was Oct 1, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a LZO 510(k)?

For the 25 LZO clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 102 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most LZO clearances?

Since 2011: Medacta International S.A. (24), Corin USA (17), Microport Orthopedics, Inc. (13), Smith & Nephew, Inc. (12) and Waldemar Link GmbH & Co. KG (11). 56 applicants have cleared a LZO device in that time.

Sources

  1. FDA product classification: LZO · Product Classification database
  2. 21 CFR 888.3353: Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for LZO · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow LZOGet an email when FDA clears, recalls or publishes guidance for LZO devices.

Know what FDA already cleared.